kidneys and semaglutide Semaglutide, Chronic Kidney Disease, Diabetes Diabetes Distilled: Keeping kidneys FLOWing

Purpose of Review This review explores the rationale and available evidence behind incretin-based therapies for metabolic dysfunction-associated steatotic disease (MASLD) and metabolic-associated steatohepatitis (MASH), focusing on glucagon-like peptide 1 (GLP-1) and glucagon (GCG) receptor dual agonists (GLP-1/GCG RAs)

Improve digestion, energy, and nutrient absorptiondoctor-formulated

Andrew Blauvelt, MD, shared his insights on the use of GLP-1s for treating patients with psoriasis.

A natural GLP-1 activator and appetite suppressant made with plant-based ingredients.

PlexusDx explains the science behind each phase of your treatment timeline